EU regulator starts real-time review of Merck's COVID-19 pill
Go back to EU regulator starts real-time review of Merck's COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 149.86 +2.10 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.76 | 52 Week High | $65.46 | |||
| Open | $150.23 | 52 Week Low | $47.97 | |||
| Day High | $151.68 | P/E | 101.95 | |||
| Day Low | $148.55 | EPS | $1.47 | |||
| Volume | 9,652,584 | |||||

